GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:17440987
Citation |
Egeblad, M, Shen, HC, Behonick, DJ, Wilmes, L, Eichten, A, Korets, LV, Kheradmand, F, Werb, Z and Coussens, LM (2007) Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development. Dev. Dyn. 236:1683-93 |
---|---|
Abstract |
Recessive inactivating mutations in human matrix metalloproteinase 2 (MMP2, gelatinase A) are associated with syndromes that include abnormal facial appearance, short stature, and severe bone loss. Mmp2(-/-) mice have only mild aspects of these abnormalities, suggesting that MMP2 function is redundant during skeletal development in the mouse. Here, we report that Mmp2(-/-) mice with additional mutations that render type I collagen resistant to collagenase-mediated cleavage to TC(A) and TC(B) fragments (Col1a1(r/r) mice) have severe developmental defects resembling those observed in MMP2-null humans. Composite Mmp2(-/-);Col1a1(r/r) mice were born in expected Mendelian ratios but were half the size of wild-type, Mmp2(-/-), and Col1a1(r/r) mice and failed to thrive. Furthermore, composite Mmp2(-/-);Col1a1(r/r) animals had very abnormal craniofacial features with shorter snouts, bulging skulls, incompletely developed calvarial bones and unclosed cranial sutures. In addition, trabecular bone mass was reduced concomitant with increased numbers of bone-resorbing osteoclasts and osteopenia. In vitro, MMP2 had a unique ability among the collagenolytic MMPs to degrade mutant collagen, offering a possible explanation for the genetic interaction between Mmp2 and Col1a1(r). Thus, because mutations in the type I collagen gene alter the phenotype of mice with null mutations in Mmp2, we conclude that type I collagen is an important modifier gene for Mmp2. Developmental Dynamics 236:1683-1693, 2007. (c) 2007 Wiley-Liss, Inc. |
Links |
PubMed PMC2581616 Online version:10.1002/dvdy.21159 |
Keywords |
Animals; Bone Density; Bone Diseases, Metabolic/genetics; Bone Diseases, Metabolic/metabolism; Bone Diseases, Metabolic/pathology; Bone and Bones/metabolism; Collagen Type I/metabolism; Craniofacial Abnormalities; Edema/genetics; Edema/metabolism; Edema/pathology; Gene Expression Regulation, Developmental; Humans; Joints/abnormalities; Joints/metabolism; Matrix Metalloproteinase 2/deficiency; Matrix Metalloproteinase 2/genetics; Matrix Metalloproteinase 2/metabolism; Mice; Mice, Transgenic |
edit table |
Significance
Annotations
Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
---|---|---|---|---|---|---|---|---|
edit table |
See also
References
See Help:References for how to manage references in GONUTS.